EOSINOPHIL PEROXIDASE AND MACROPtlAGE-MEDIATED CYTOLYSIS extracted with 0.05 M sodium acetate buffer, pH 4.7, containing 0.18 M sodium chloride, and the enzyme purified by chromatography on Sephadex G-200 and carboxymethylcellulose. The final product, which was present in 0.05 M sodium acetate buffer, pH 4.7, with 1.0 M sodium chloride, had a 415/280 nm optical density ratio of >0.9. Peroxidase activity was determined by guaiacol oxidation (27) . 1 U of enzyme is the amount that oxidizes 1/~mol of guaiacol/min at 25°C, using a molar absorbancy for the product, tetraguaiacol, of 2.66 × 104 cm -1 at 470 nm (28) . The activity of freshly prepared stock solutions ranged from 112 to 340 U/ml. Aliquots (10-50/H) of the EPO preparation were frozen in microhematocrit tubes and thawed just before use~ Treatment of Tumor Cells with EPO. Tumors were carried as ascites in the mouse strains indicated: LSTRA lymphoma (BALB/c), TLX9 and NK lymphomas (C57BL/6), and P815 mastocytoma [(BALB/c × DBA/2)FI (CD2F,)]. TLX9 and P815 were also maintained for up to 3 wk in stationary suspension culture in Eagle's minimum essential medium (alpha variant) with 100/~g/ml streptomycin and 100 U/ml penicillin, containing 10% horse serum heated at 56°C for 30 rain (MEM-10% HS). Tumor cells were labeled with Na251CrO4 as previously described (ref. 29 for LSTRA; ref. 30 for TLX9, NK, and P815). For coating of tumor cells with EPO, 15 × 106 LSTRA cells in 0.5 ml of Hanks' balanced salt solution containing 0.001% gelatin and 10 mM glucose, or 1 × 106-3 × 106 TLX9, NK, or P815 cells in 0.5 ml of KrebsRinger buffer containing 6 mM phosphate and 5.5 mM glucose, were incubated with 10-20 /H of the EPO preparation for 10-15 rain at 37°C. The dilution of the stock EPO preparation was >25 times, so that the final acetate buffer and sodium chloride concentrations contributed by the enzyme preparations were <0.002 M and 0.04 M, respectively. The cells were washed twice and suspended in 0.1 M phosphate buffer pH 7.0 (for LSTRA), MEM-5% HS (for TLX9 and P815), or MEM-0.25% HS (for NK lymphoma). Control (uncoated) tumor cells were treated identically, except that EPO was not added. The cells were counted and viability assessed with 0.2% trypan blue in a hemocytometer.
Effector Cells. Peritoneal cells were collected from untreated or variously injected CD2FI female mice, washed, enumerated, and counted differentially as described in detail elsewhere (2, 3, 5) . The cells were suspended at 3 × 105/0.1 ml of MEM-5% HS (for use with TLX9 or P815 cells) or MEM-0.25% HS (for use with NK lymphoma cells), except where noted otherwise. Where indicated, 7 × 106 peritoneal cells in 2 ml Krebs-Ringer buffer were layered on top of 3 ml of Ficoll-Paque (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N J) in a 15-ml tube, and centrifuged at 300 g for 10 min at 4°C. The upper, mononuclear cell layer was washed three times in the medium used for the assay.
Cytolysis Assay. For studies performed in the absence of effector cells, uncoated and EPOzoated target cells were incubated with the components of the reaction mixture as described in the legends to Tables and Figures. With LSTRA, the reaction was conducted in 10 × 75-mm polystyrene test tubes (2054; Falcon Labware, Oxnard, CA) and ~Cr release determined as previously described (29) . With the other tumor cells, microtest plates were used as described below.
For studies using effector cells and target cells, 0.1 ml of each were dispensed to roundbottomed microtest plates (Flow Laboratories, Rockville, MD) containing 0.02 ml of phorbol myristate acetate (PMA) diluted in dimethylsulfoxide (DMSO) or DMSO alone (final concentration, 0.033% DMSO with or without 100 ng/ml PMA). Where indicated, catalase (from beef liver, type C100, Sigma Chemical Co., St. Louis, MO) or sodium azide (Fisher Scientific Co., Pittsburgh, PA) were diluted in normal saline and added in a volume of 0.02 ml to the assay wells. Catalase was inactivated by boiling for 20 min, reconstituting to the original volume with distilled water, and sonicating 15-30 s (power output I, Heat Systems-Ultrasonics Inc., Plainview, NY) to disperse the precipitate. The plates were incubated at 37°C in 5% COz/ 95% air for 4.5 h and centrifuged. Gamma emissions were counted in 0.1 ml of each supernatant. Percent specific lysis for triplicate cultures was calculated as (A -B)/(C -B), where A equals percent release of ~lCr in the presence of effector cells, B equals percent release in the absence of effectors, and C equals percent of the total label that was releasable in the presence of 0.2% Triton X-100 (Sigma Chemical Co.). The simple proportional SEM for triplicates was calculated as before (3) . In this paper, "spontaneous release" refers to term B as defined above, whereas "spontaneous lysis" refers to specific lysis in the presence of effector cells but in the absence of PMA.
Percent Inhibition. Inhibition of EPO-dependent cytolysis by catalase or azide was expressed as 100 (D -E + F)/D, where D equals specific lysis of EPO-coated tumor cells in the absence of catalase or azide, E equals specific lysis of EPO-coated targets in the presence of either agent, and F equals specific lysis of targets not coated with EPO. The value of F averaged 8.2% and was the same whether or not catalase or azide was present. In computing E, the term for spontaneous release pertained to tumor cells incubated with the same concentration of catalase or azide but without effector cells. No concentration of either agent as used here significantly affected the spontaneous release of 51Cr.
Other Reagents and Procedures. 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) was from Bristol Laboratories, Syracuse, NY. Where indicated, protamine sulfate (preservative free; Eli Lilly and Co., Indianapolis, IN) was used in place of EPO at a concentration of 0.06 mg/ml. Glucose oxidase (GO) from Aspergillus niger (Type V) was from Sigma Chemical Co. The rate of production of H202 was assayed by the scopoletin method (2) . All other details of procedure, and the sources of mice and materials, were as previously reported (3, 5, 30) .
Results

Increased Sensitivity of EPO-coated Tumor Cells to Lysis by H202.
In an earlier study (25) , EPO from guinea pig peritoneal cells sensitized LSTRA lymphoma cells to lysis by 10 .4 M preformed H202 in the presence of a halide. We confirmed this finding with a highly purified preparation of horse EPO, and in addition determined the effect of allowing the EPO to bind to the surface of the tumor cells by preincubation. Table I demonstrates the toxic effect of H202 and a halide on LSTRA lymphoma cells with surface-bound EPO. Each component of the toxic system (EPO, H202, and halide) was required. The hemeprotein inhibitors azide, cyanide, and aminotriazole decreased the toxicity. Under the conditions used, iodide was effective at concentrations down to 10 .5 M and bromide to 10 .4 M. Chloride was ineffective at 0.1 M. Damage to EPO-coated tumor cells was evident within 5 min of incubation with H202 and iodide, and reached a maximum at 30 min, under the conditions used in Table II .
Protein inhibits the toxicity of the free peroxidase-H202-halide system. However, cytotoxicity mediated by cell-bound EPO was markedly less sensitive to inhibition by protein. This is shown in Table III . When free EPO was used, human serum albumin inhibited toxicity partially at a concentration of 4 mg/100 ml and completely at 40 mg/100 ml. In contrast, an albumin concentration of 8 g/100 ml was required for inhibition when EPO was bound to the target cell surface. Similarly, 0.05% serum partially and 0.2% serum completely inhibited toxicity with free EPO, whereas with cell-bound EPO, 30% serum caused only partial inhibition, and inhibition was incomplete at the highest serum concentration employed (40%).
We next undertook studies with three additional tumor cell lines (TLX9 lymphoma, P815 mastocytoma, and NK lymphoma), which vary widely in their susceptibility to lysis by H202 (TLX9 > P815 > NK) (30) , and have been used in earlier studies of the role of H2Oz in macrophage-mediated cytotoxicity (3, 5, 30) . To mimic the manner in which HzO2 is delivered by macrophages, we added glucose oxidase (GO) plus glucose, thereby generating a flux of H202. We suspended the tumor cells in a complex, serum-containing medium at pH 7.4, without additional iodide or bromide.
The tumor cells were exposed to EPO and then washed to remove unbound enzyme. Such cells showed no signs of toxicity, compared with cells without surfacebound EPO, as judged by exclusion of trypan blue or retention of SlCr (Table IV) . * The reaction mixture contained 3 X 10 -2 M sodium phosphate buffer pH 7.0, 1.5 × 10 -a M MgSO4, 1.5 X 10 -a M KH2PO4, 6.7 X 10 -2 M Na2SO4, 0.005% gelatin, and the supplements where indicated as follows: l0 s SlCr LSTRA tumor cells with bound EPO (LSTRA-EPO); 10 -5 M H202, and iodide, bromide, chloride, azide, cyanide, or aminotriazole (sodium salts) at the concentrations indicated. In tubes with "EPO omitted", LSTRA cells were used without preincubation with EPO, and when 0.1 M NaCI was used, the 6.7 X 10 -2 M Na2SO4 was deleted. Incubation 30 min. P value for the difference from the complete system (LSTRA-EPO + H202 + 10 -5 M iodide). § P value for the difference from the standard salt solution alone (None). H Mean + SE of (n) experiments. ¶ Not significant. The reaction mixture was as described in Table I with either LSTRA-EPO alone (control) or LSTRA-EPO + H202 + I-(10 -~ M). Incubation was for the period indicated. (4) 51.3 ± 7.5 (4) <0.002 NS 9.4 + 1.4 (4) 41.5 ± 9.3 (4) <0.02 NS 10.4 ± 2.4 (3) 24.9 ± 11,2 (3) NS <0.02
11,4 + 1.6 (4) 65.7 ± 2.4 (4) <0.001 NS 11.6 + 1.3 (4) 59.1 ± 4.2 (4) <0.001 NS 11.6 ± 1.4 (4) 49.9 + 3.2 (4) <0.001 <0.02 10.9 ± 2.4 (3) 40.4 ± 0.9 (3) <0.001 <0.002 * The reaction mixture was as described in Table I with either LSTRA cells and free EPO ("EPO') or LSTRA with surface-bound EPO (~q,STRA-EPO"). Control tubes did not contain any other components of the peroxidase system whereas the complete EPO system contained 224 mU EPO, 10 5 M H20,e, and 10 4 M iodide. Human serum albumin or pooled human serum was added at the concentrations indicated. * P value for the difference between the control and complete system § P value for the difference between the complete system with albumin or serum and the complete system without albumin or serum. II Mean ± SE of (n) experiments.
¶ Not significant. Moreover, mice injected with 106 EPO-coated P388 cells died at 10.7 + 0.4 d, which was no later than mice injected with control P388 cells (11.4 + 0.7 d, seven mice per group). However, when exposed to GO plus glucose, EPO-coated TLX9 lymphoma cells were 15 times more sensitive and NK lymphoma cells 76 times more sensitive to lysis by H202 than were control, uncoated tumor cells, as judged by the flux of H202 required for 50% specific lysis (Fig. 1) . EPO alone did not affect the amount of GO necessary to attain 50% lysis of P815 mastocytoma cells (Table V) A range of concentrations of GO in 0.02 ml of normal saline was added to individual wells, and 51Cr release determined after 4.5 h of incubation. Glucose was at a higher molarity with NK cells so that higher concentrations of GO could be tested without depleting the medium of glucose. The rate of HzOz generation by GO was measured in Krebs-Ringer phosphate buffer with 5.5 mM or 40 mM glucose, using the scopoletin method, and is indicated on a logarithmic scale on the abscissa. Data points are means of triplicates, for which SEM averaged 2.6 :k 0.5%. Spontaneous release of 51Cr in the absence of GO was: 7.5% (TLXg, EPO-); 7.0% (TLX9, EPO+); 13.0% (NK, EPO-); 10.8% (NK, EPO+). NK lymphoma cells were more sensitive to GO than in a previous study (30) presumably because the serum concentration was lower. * The reaction mixture was as described in Fig. 1 except that 2 × 104 P815 cells in 0.2 ml of MEM-5% HS containing 5.5 mM glucose were used. The cells were either untreated, coated with EPO, incubated with 100/~g/ml of BCNU for 10 min, or both coated with EPO and treated with BCNU. The nmol of H202/min generated by the amount of glucose oxidase needed to produce 50% specific ~ICr release in 4.5 h (LD~0) was determined.
P815 cells and sensitizes them to peroxide-mediated lysis (30) . As shown in Table V , the sensitivity of P815 cells to H202 was increased four-to fivefold by prior exposure to BCNU. The sensitivity of BCNU-treated P815 cells to H202 was further increased 2.8-fold by surface-bound EPO.
Augmentation of PMA-triggered, Macrophage-mediated Cytolysis by EPO.
We next tested the effect of EPO on cytolysis caused by H202 secreted by macrophages in response to PMA (4). EPO-coated tumor cells were much more readily lysed by PMA-triggered, bacillus Calmette-Gu~rin (BCG)-elicited macrophages than were native tumor cells (Table VI) . With the relatively peroxide-resistant NK lymphoma (30) , no macrophage-mediated lysis of tumor cells was observed without EPO, whereas 100% lysis was attained when PMA-triggered, BCG-elicited macrophages were incubated with EPO-coated NK lymphoma cells at effector/target (E/T) ratios of 5:1 to 45:1 (Table VI , Fig. 2 ). Similarly, in one experiment, EPO on the surface of NK lymphoma ceils greatly increased their sensitivity to lysis by PMA-triggered, casein-induced macrophages. Resident macrophages, however, did not lyse control or EPO-coated NK targets under our experimental conditions (Table VI) . With TLX9 lymphoma cells, the partial lysis observed when uncoated tumor cells were exposed to PMA-triggered, BCG-elicited peritoneal cells was considerably increased when the target cells were coated with EPO (Table VI, Fig. 3) . Comparison of E/T ratios at 50% lysis (0.3 for coated and 9.6 for uncoated TLX9) suggested that PMA-stimulated, BCG-elicited peritoneal cells were ~32 times more efficient at lysing EPO-coated TLX9 than native TLX9 (Fig. 3) . Even peritoneal cells elicited with thioglycollate medium lysed EPO-coated targets in the presence of PMA. Resident peritoneal cells did so in one of four experiments (Fig. 3) .
Spontaneous Macrophage-mediated Cytolysis of EPO-coated Tumor Cells. In contrast to uncoated target cells, EPO-coated NK and TLX9 lymphoma cells were lysed to a substantial extent by BCG-elicited peritoneal cells in the absence of PMA (Table VI and Figs. 2 and 4) . Caseinate-elicited cells were also effective in one experiment with NK lymphoma cells (Table VI) . Peritoneal exudates enriched in granulocytes were collected 16-20 hours after intraperitoneal injection of sodium caseinate, thioglycollate medium, or proteosepeptone. Such granulocyte-rich exudates had little spontaneous cytolytic activity against EPO-coated targets, even at high E/T ratios (Table VI) . In contrast, BCGelicited peritoneal ceils, which had been depleted almost completely of granulocytes 
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on Ficoll-Hypaque, were still cytolytic (Table VI) . These results suggested that activated macrophages, rather than granulocytes, mediated spontaneous cytolysis.
BCG-elicited peritoneal ceils spontaneously lysed 50% of EPO-coated TLX9 cells in 4.5 h at a peritoneal cell/tumor cell ratio of 3.6, corresponding to a macrophage/ tumor cell ratio of 1.5 (Fig. 4) . In contrast, at E/T ratios as high as 15:1 to 45:1, resident peritoneal cells and cells elicited with thioglycollate medium remained ineffective (Table VI and Fig. 4) . If TLX9 cells were not exposed to EPO, then BCGactivated macrophages caused <10% spontaneous lysis under the conditions tested (Fig. 4) .
In one experiment with P815 mastocytoma, BCG-elicited cells released 33% of the 51Cr from the tumor cells in 4.5 h at an E/T ratio of 4.6, when the tumor cells were first exposed to both EPO and BCNU as described in Table V . When either EPO or BCNU was omitted, lysis was not observed.
The spontaneous lysis of EPO-coated tumor cells by BCG-activated macrophages reached 50% of its maximum value in -1 h, and approached a plateau at ~3 h (Fig.  5 ). In contrast, there was almost no lysis of control tumor cells by 8 h. Resident peritoneal cells failed to lyse EPO-coated tumor cells spontaneously even after 20 h (data not shown).
In a dose-response experiment, spontaneous lysis of TLX9 cells by BCG-elicited peritoneal cells increased from 5% for control TLX9 cells to a maximum of 89% for TLX9 cells incubated with 0.6 U of EPO and then washed. Half-maximal lysis followed exposure to 0.3 U EPO. To determine how much of the EPO bound to the tumor cells, peroxidatic activity was measured immediately after adding the enzyme to the tumor cell suspension; after a 10-min incubation under standard conditions (see Materials and Methods), the cells were washed four times by centrifugation, and peroxidatic activity was determined again. Both the initial and final assays were done in the presence of 0.04% Triton X100. In four such experiments (two each with TLX9 and NK lymphomas), 22 + 5% of the enzymatic activity of the added EPO remained bound to the tumor ceils.
Lysis of EPO-coated tumor ceils by macrophages has been called spontaneous because no additional agent such as PMA was required. However, it was possible that EPO itself, or EPO-coated tumor cells, might act like PMA and stimulate a burst of HzO~ secretion by activated macrophages (2) . If this were the case, then non-EPOcoated, peroxide-sensitive tumor cells present in the same culture should be lysed as "innocent bystanders" by the interaction of EPO-coated tumor cells with macrophages. As shown in Table VII , no such lysis was observed, although the bystander cells were readily lysed after addition of PMA. Finally, EPO itself elicited no detectable HzO2 release from BCG-activated macrophages, as detected by the scopoletin assay (data not shown).
Dependence of Cytolysis on H2Oz.
In six experiments, catalase inhibited the spontaneous lysis of EPO-coated TLX9 or NK lymphoma cells by BCG-elicited peritoneal cells by an average of 98% (Table VIII) . Catalase which had been inactivated by heating had little or no inhibitory effect (Table VIII) . 23 U of catalase/ml inhibited cytolysis by 50% (Fig. 6B ). Results were similar with PMA-induced cytolysis of EPO-coated targets (e.g., Fig. 7) . Thus, both PMA-induced and spontaneous cytolysis appeared to depend on H202. granules of eosinophils (31) or neutrophils (32) may be tumoricidal independent of peroxidase activity. EPO, although a cationic protein, did not seem to exert its toxicity through this property under our conditions, because EPO was nontoxic in the absence of H202 (Table IV) . That EPO was functioning enzymatically in promoting cytolysis was further suggested by two additional approaches. First, the peroxidase inhibitor sodium azide inhibited spontaneous lysis of EPOcoated TLX9 or NK lymphoma cells by BCG-activated macrophages by a mean of 102% in four experiments (Table IX) . Azid~ at 2.6 X 10 -5 M afforded 50% inhibition (Fig. 6 A) . Sodium azide would not be expected to affect nonenzymatic functions of EPO related to its cationic nature. Second, we exposed NK lymphoma cells to protamine sulfate, a cationic protein (33) lacking in peroxidase activity. Preliminary experiments demonstrated that protamine sulfate alone was toxic to NK lymphoma cells (data not shown). The highest concentration of protamine sulfate that did not itself elevate the spontaneous release of 51Cr from the tumor cells was 0.06 mg/ml. NK lymphoma cells exposed to this concentration of protamine sulfate were unharmed by BCG-activated macrophages, with or without PMA, whereas the tumor cells exposed to EPO (<0.02 mg/ml) were extensively lysed by the macrophages (Fig. 7) . As before, lysis was abolished by catalase (Fig. 7) . Discussion Many reports have documented that myeloperoxidase, lactoperoxidase, or EPO can enhance the lysis of tumor cells by H202 and halide, whether the H202 is preformed, generated by enzymes in situ, or released by leukocytes stimulated with particles, lectins, or phorbol esters (25, 29, (34) (35) (36) (37) (38) (39) (40) . The work reported here extends such observations in two ways.
Dependence of Cytolysis on the Enzymatic Action of EPO. Cationic proteins from the
First, EPO catalyzed the lysis of tumor cells by H202 released spontaneously from activated macrophages in the absence of exogenous triggering agents. This constitutes a new, unusually rapid, and potent form of spontaneous macrophage-mediated cytolysis. Second, this peroxidase-dependent cytotoxicity occurred in a complex, serum-containing tissue culture medium without further addition of halides. The medium was physiologic, in that it could support the replication of TLX9, P815, and P388 tumor cells at approximately the same rate as in the peritoneal cavity (C. Nathan, unpublished observations). When peroxidases are in solution, their cytotoxic effects are readily inhibited by serum proteins, which compete with cells for the toxic products of the peroxidase system. In contrast, EPO, which is highly cationic (pI > 11) (21) , bound to the surface of tumor cells, where it efficiently promoted peroxidedependent cytotoxicity, despite the presence in the medium of competing compounds such as serum proteins.
Cell-bound EPO sensitized each of four different types of tumor cells to H20~. For three of these, we quantified the degree of sensitization to enzymatically generated H202. TLX9 lymphoma cells, which are relatively sensitive to H202 (30), became -15 times more sensitive after exposure to EPO. NK lymphoma cells, which are comparatively resistant to H202 (30) , became up to 76-fold more susceptible after treatment with EPO. As a consequence, there were fluxes of H202 that lysed none of the control tumor cells, but essentially all of the EPO-coated cells. On the other hand, the peroxide sensitivity of P815 mastocytoma cells, which is normally intermediate between TLX9 and NK cells, did not appear to be affected by EPO alone. However, when EPO-treated P815 cells were also exposed for 10 min to BCNU to inactivate glutathione reductase, an enzyme involved in H20~ catabolism (30), they became 13 times more sensitive to H202 than cells treated with neither EPO nor BCNU (2.8 times more sensitive than cells treated with BCNU alone). The basis for this variation in response to EPO among different tumors is unknown, but could relate to differences in binding of the enzyme.
The spontaneous lysis of EPO-coated tumor cells by activated macrophages was rapid (50% at 2 h at a macrophage/tumor cell ratio of 6:1). In contrast, control target cells were almost completely spared during an 8-h incubation with activated macrophages. In assays lasting 4.5 h, macrophage/tumor cell ratios of 1.5:1 to 4.6:1 produced 50% spontaneous lysis of EPO-coated targets. Macrophages activated by injection of mice with either BCG or sodium caseinate were able to lyse EPO-coated tumor cells spontaneously. However, resident peritoneal macrophages or macrophages elicited with thioglycollate medium were ineffective, and peritoneal granulocytes showed marginal cytolytic activity only at high E/T ratios. Spontaneous lysis of EPOcoated tumor cells by activated macrophages was inhibited completely by catalase, with 50% inhibition by 23 U/ml, but not by boiled catalase. Thus, spontaneous cytolysis appeared to require H202.
We attributed spontaneous cytolysis in this setting to macrophages, for the following reasons. A low level of spontaneous secretion of H202 by activated macrophages has been measured biochemically (2) , and is consistent with the known elevation ofhexose monophosphate shunt activity in activated macrophages at rest (41) (42) (43) (44) (45) . In contrast, secretion of H202 by BCG-elicited peritoneal lymphocytes could not be detected (2) . Very tow levels of spontaneous cytolysis of EPO-coated tumor cells resulted from incubation with large numbers of peritoneal granulocytes. However, granulocytedepleted populations, consisting almost exclusively of macrophages and lymphocytes, remained spontaneously cytolytic.
We have referred to cytolysis as spontaneous when there was no requirement for exogenous agents known to trigger macrophages. EPO itself did not appear to be such an agent. EPO did not elicit detectable H202 release from activated macrophages, nor did EPO-coated tumor cells induce macrophages to lyse tumor cells not coated with EPO. However, as with any system of apparently spontaneous cytotoxicity, it is possible that stimuli endogenous to the assay may have elicited a cytotoxic response. Such stimuli could include components of the medium, the surface of the culture vessel, or the tumor cells themselves (46) .
EPO is a cationic protein, and like other granulocyte cationic proteins (31, 32), might be tumoricidal by virtue of this property. However, no cytotoxicity was seen with EPO unless H202 was added. The cytotoxicity of EPO plus H2Oz was abolished completely by low concentrations of the peroxidase inhibitor sodium azide (50% inhibition at 2.6 × 10 -5 M). This agrees closely with the concentration of azide found previously to inhibit the enzymatic activity of EPO (47) . Azide did not inhibit cytotoxicity by reducing macrophage H202 production (data not shown). When tumor cells were not exposed to EPO, then PMA-triggered cytolysis by macrophages was either unaffected by azide or augmented by it (4). Finally, protamine sulfate, a cationic protein (pI ~ 12) (33), which was cytotoxic in the absence of added H202 at relatively high concentrations, did not support the expression of spontaneous cytotoxicity by activated macrophages at protein concentrations at least threefold greater than those at which EPO was effective.
It is not known to what extent eosinophils release their granule contents in a tumor bed, or with what efficiency EPO might bind to tumor cells in vivo. However, under our experimental conditions, the EPO contained in ~8 × 104 eosinophils appeared to be sufficient to sensitize 1 × 106 TLX9 lymphoma cells to undergo 89% specific lysis in the presence of 8 × 10 a BCG-activated macrophages. By this estimate, the peroxidase in 1 eosinophil could augment maximally the spontaneous in vitro cytolytic capacity of 100 macrophages.
Titrations of the cytolytic activity of peritoneal cells and of glucose oxidase plus glucose suggest that BCG-activated macrophages would produce the observed degree of lysis of EPO-coated tumor cells if the macrophages spontaneously released about 0.26 nmol of H202 per rain. This figure is an order of magnitude higher than the rate of spontaneous H202 release previously observed with BCG-activated macrophages in suspension (0.02 nmol/min) (2). There are several possible explanations for this apparent discrepancy.
First, the proximity of macrophages to tumor cells may have raised the local concentration of H202 to a level higher than would be achieved by soluble glucose oxidase with the same rate of H202 generation. Second, the peritoneal cell preparations may have supplied factors augmenting the efficiency of EPO. Thus, production of acid by macrophages in the vicinity of tumor cells may have lowered the pericellular pH. At the same concentrations of H202 and EPO, there is far more toxicity to tumor cells at pH 6 than at pH 7 (25) . Peritoneal cell preparations may have supplied traces of a halide or other oxidizable cofactor. Iodide exerts a synergistic effect with chloride in permitting the halide-dependent toxicity of the EPO-H202 system (25) . In addition, the BCG-elicited peritoneal cell populations contained 0.75 -¢-0.25% mast cells (mean + SEM, n = 12). H202 triggers mast cell degranulation (38, 48, 49) and mast cell granules markedly enhance the cytotoxicity of EPO for tumor cells (38) .
Finally, macrophages secrete additional cytotoxic substances besides H202 (8) (9) (10) (11) . One of these, termed cytolytic factor (11), can exert a synergistic effect together with H202, so that tumor cells are lysed at concentrations of each substance which are not cytolytic separately (50) . Thus, whereas H202 was necessary for spontaneous macrophage-mediated cytolysis of EPO-coated targets, other factors may have increased the efficiency of lysis.
The findings presented here and earlier (50) raise the possibility that spontaneously secreted H202 may contribute, along with other factors, to the cytotoxicity occurring during more prolonged contact of activated macrophages with tumor cells (51) in the absence of EPO. In summary, an enzyme from eosinophils and an inorganic substrate released spontaneously by activated macrophages together lysed tumor cells that were unharmed by either agent alone. Cytotoxicity was rapid and potent, and occurred readily in a medium with a composition similar to that of extracellular fluid. These features encourage the speculation that macrophages and eosinophils may cooperate in exerting extracellular cytotoxicity when they migrate together into tumor beds, sites of parasitic infestation, or other foci of inflammation.
Summary
Eosinophil peroxidase (EPO), a cationic protein purified from horse blood, adhered to four different types of tumor cells, markedly potentiating their lysis by preformed or enzymatically generated H202 (up to 76-fold, as assayed in serum-containing tissue culture medium without supplemental halide). Similarly, compared with uncoated tumor cells, EPO-coated tumor cells were up to 32 times more sensitive to lysis when incubated with macrophages or granulocytes whose respiratory burst was triggered by PMA. However, EPO-coated tumor cells were also readily lysed by bacillus Calmette-Gu6rin-activated macrophages in the absence of exogenous triggering agents. This spontaneous cytolysis was rapid (50% at 2 h) and potent (50% lysis at macrophage/tumor cell ratios of 1.5 to 4.6), and was observed with both a peroxide~ sensitive tumor (TLX9) and a peroxide-resistant tumor (NK lymphoma). Under the conditions used, neither EPO alone nor macrophages alone were spontaneously cytolytic. Neither EPO nor EPO-coated tumor cells triggered a detectable increment in H202 release from macrophages. Nonetheless, spontaneous macrophage-mediated cytolysis of EPO-coated tumor cells was completely inhibitable by catalase (50% inhibition, 23 U/ml), although not by heated catalase, indicating a requirement for H202. Cytolysis was also completely inhibitable by azide (50% inhibition, 2.6 X 10 -5 M), indicating a requirement for enzymatic activity of EPO. Thus, a cytophilic peroxidase from eosinophils and H202 spontaneously released from activated macrophages interacted synergistically in a physiologic medium to destroy tumor cells.
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